fda warning letters compounded semaglutide november 2025 Hers Compounded Semaglutide: Safety, Availability, and Safer Wegovy Alternatives in 2026

Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide

23.44

★★★★☆4.8 (126)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

20.79

★★★★★4.9 (98)

The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP-1s, which are not FDA-approved and can pose risks to patients. FULL STORY:🔗https://tinyurl.com/3ztf9uj2

20.69

★★★★★5.0 (157)

Semaglutide: The Drug of Today and a Steppingstone to Tomorrow

21.63

★★★★★4.7 (84)

We're warning consumers of concerns with compounded medications containing semaglutide: https://www.fda .gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing- semaglutide-marketed-type-2-diabetes-or-weight-loss

19.98

★★★★★4.9 (203)

FDA hits Ozempic and Mounjaro counterfeit compounders with warning letters

26.05

★★★★★5.0 (176)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

24.84

★★★★★4.8 (132)